Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Powell

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 24, 1997
Insulin-like growth factor binding protein-1: recent findings and new directionsP D Lee, L C Giudice, C A Conover, et al.
Endocrinology|August 1, 1996
Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoidC A Conover, P D Lee, B L Riggs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
NF-ATc isoforms are differentially expressed and regulated in murine T and mast cellsM A Sherman, D R Powell, D L Weiss, et al.
Endocrinology|August 31, 2000
Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivityC A Conover, L K Bale, S K Durham, et al.
The Journal of Organic Chemistry|June 21, 2003
A comparison of monocyclic and bicyclic phospholanes as acyl-transfer catalystsE Vedejs, O Daugulis, L A Harper, et al.
Biochemical and Biophysical Research Communications|July 16, 1986
Purification of the insulin-like growth factor II (IGF-II) receptor from an IGF-II-producing cell line, and generation of an antibody which both immunoprecipitates and blocks the type 2 IGF receptorR G Rosenfeld, D Hodges, H Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1987
Antiserum developed for the E peptide region of insulin-like growth factor IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassayD R Powell, P D Lee, D Chang, et al.
Genomics|March 1, 1992
Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7E Ehrenborg, C Larsson, I Stern, et al.
Journal of Medicinal Chemistry|March 1, 1984
Phosphorus-nitrogen compounds. 24. Phosphoramide mustard carrier derivativesL A Cates, V S Li, D R Powell, et al.
Pediatric Nephrology (Berlin, Germany)|June 1, 1996
Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failureD R Powell, F Liu, B K Baker, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 24, 1997
Insulin-like growth factor binding protein-1: recent findings and new directionsP D Lee, L C Giudice, C A Conover, et al.
Endocrinology|August 1, 1996
Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoidC A Conover, P D Lee, B L Riggs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
NF-ATc isoforms are differentially expressed and regulated in murine T and mast cellsM A Sherman, D R Powell, D L Weiss, et al.
Endocrinology|August 31, 2000
Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivityC A Conover, L K Bale, S K Durham, et al.
The Journal of Organic Chemistry|June 21, 2003
A comparison of monocyclic and bicyclic phospholanes as acyl-transfer catalystsE Vedejs, O Daugulis, L A Harper, et al.
Biochemical and Biophysical Research Communications|July 16, 1986
Purification of the insulin-like growth factor II (IGF-II) receptor from an IGF-II-producing cell line, and generation of an antibody which both immunoprecipitates and blocks the type 2 IGF receptorR G Rosenfeld, D Hodges, H Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1987
Antiserum developed for the E peptide region of insulin-like growth factor IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassayD R Powell, P D Lee, D Chang, et al.
Genomics|March 1, 1992
Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7E Ehrenborg, C Larsson, I Stern, et al.
Journal of Medicinal Chemistry|March 1, 1984
Phosphorus-nitrogen compounds. 24. Phosphoramide mustard carrier derivativesL A Cates, V S Li, D R Powell, et al.
Pediatric Nephrology (Berlin, Germany)|June 1, 1996
Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failureD R Powell, F Liu, B K Baker, et al.
Pageof 13